Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 89

Sort by

Sort Order Select

Journal Articles

A 3D Niche Nanobioreactor Supports Long-Term Tracking of Hematopoietic Stem and Progenitor Cell Cycle Kinetics, Self-Renewal and Cell Fate Determination

Jenna S Sneifer, Jessica Pham, Inge Van Der Werf, Larissa Balaian, Emma E Klacking, Neha Katragadda, Luisa Ladel, Anna Kulidjian, Patrick Chang, Thomas Whisenant, Catriona Jamieson

Blood (2024) 144 (Supplement 1): 4068.

https://doi.org/10.1182/blood-2024-212259

Published: 2024

Journal Articles

Space-Associated Stem and Hematopoietic Cell Aging in Astronauts on Short-Duration Missions

Jessica Pham, Larissa Balaian, Patrick Chang, Shuvro P Nandi, Jenna S Sneifer, Antonio W Ruiz, Emma E Klacking, Inge Van Der Werf, Karla Mack, Neha Katragadda, Claire Engstrom, Cristian Quintero, Jane Isquith, Pinar Mesci, Elsa Molina, Jana Stoudemire, Thomas Whisenant, Ludmil Alexandrov, Catriona Jamieson

Blood (2024) 144 (Supplement 1): 5628.

https://doi.org/10.1182/blood-2024-212357

Published: 2024

Journal Articles

Selective Reversal of ADAR1 Splicing Prevents Leukemia Stem Cell Maintenance In Vivo

Wenxue Ma, Catriona Jamieson, Jessica Pham, Emma E Klacking, Neha Katragadda, Antonio W Ruiz, Thomas P Frias, James J. La Clair, Sheldon Morris, Anna Kulidjian, Thomas Whisenant

Blood (2024) 144 (Supplement 1): 5789.

https://doi.org/10.1182/blood-2024-212092

Published: 2024

Journal Articles

Identifying the Impact of ADAR1 Inhibition on LSC Niche Remodeling in 3D Nanobioreactors

Larissa Balaian, Jessica Pham, Anna Kulidjian, Edward D. Ball, Thomas Whisenant, Michael Burkart, Catriona Jamieson

Blood (2024) 144 (Supplement 1): 1385.

https://doi.org/10.1182/blood-2024-211696

Published: 2024

Journal Articles

Defining the Roles of Base Deaminase and Splicing Deregulation in Pediatric B-Cell Acute Lymphoblastic Leukemia Stem Cell Persistence

Mrinal Joshirao, Inge Van Der Werf, Jessica Pham, Antonio W Ruiz, Neha Katragadda, Emma E Klacking, Elsa Molina, Ludmil Alexandrov, Thomas Whisenant, Catriona Jamieson

Blood (2024) 144 (Supplement 1): 1363.

https://doi.org/10.1182/blood-2024-211999

Published: 2024

Journal Articles

Malignant a-to-I RNA Editing By ADAR1 Drives T-Cell Acute Lymphoblastic Leukemia Relapse Via Attenuating dsRNA Sensing

Maria D Rivera, Jessica Pham, Jane Isquith, Haoran Zhang, Jenny Zhou, Roman Sasik, Adam Mark, Wenxue Ma, Frida Holm, Kathleen Fisch, Dennis John Kuo, Catriona Jamieson, Qingfei Jiang

Blood (2023) 142 (Supplement 1): 4147.

https://doi.org/10.1182/blood-2023-172927

Published: 2023

Journal Articles

A Longitudinal Study to Assess Hematopoietic Stem Cell and Immune Cell Health in Astronauts Pre-, during, and Post-Mission

Jessica Pham, Larissa Balaian, Emma E Klacking, Antonio W Ruiz, Jenna Sneifer, Thomas P Frias, Jane Isquith, Shuvro P Nandi, Thomas Whisenant, Elsa Molina, Jana Stoudemire, Pinar Mesci, Ludmil Alexandrov, Catriona Jamieson

Blood (2023) 142 (Supplement 1): 4056.

https://doi.org/10.1182/blood-2023-187749

Published: 2023

Journal Articles

Detection and Prevention of ADAR1p150-Induced Hematopoietic Stem and Progenitor Cell Aging

Wenxue Ma, Jessica Pham, Emma E Klacking, Antonio W Ruiz, James J. La Clair, Anna Kulidjian, Catriona Jamieson

Blood (2023) 142 (Supplement 1): 4054.

https://doi.org/10.1182/blood-2023-190582

Published: 2023

Journal Articles

Getting to the core of ADAR2 activity in AML

Kathleen Steel, Catriona Jamieson

Blood (2023) 141 (25): 3014–3015.

https://doi.org/10.1182/blood.2023019923

Published: 2023

Journal Articles

Cirmtuzumab (Zilovertamab) Eliminates ROR1 Positive Leukemia Stem Cells By Blocking Niche Dependent ROR1/WNT5a Signaling

Larissa Balaian, Mary Donohoe, Phoebe Mondala, George F. Widhopf II, Emanuela M. Ghia, Edward D. Ball, Anna Kulidjian, Inge Van Der Werf, Thomas J. Kipps, Catriona Jamieson

Blood (2022) 140 (Supplement 1): 3356–3357.

https://doi.org/10.1182/blood-2022-170128

Published: 2022

Journal Articles

Decreased Embryonic Splicing Repressor Expression Enhances Splicing Modulator Sensitivity in Pediatric Acute Myeloid Leukemia Stem Cells

Inge Van Der Werf, Kathleen Steel, Phoebe Mondala, Larissa Balaian, Jacqueline Cloos, Gertjan J.L. Kaspers, James La Clair, Peggy Wentworth, Kathleen Fisch, Leslie Crews, Thomas Whisenant, Michael Burkart, Mary Donohoe, Catriona Jamieson

Blood (2022) 140 (Supplement 1): 3354–3355.

https://doi.org/10.1182/blood-2022-171145

Published: 2022

Journal Articles

Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)

Hun Ju Lee, Michael Y. Choi, Tanya Siddiqi, Joanna M. Rhodes, William G. Wierda, Iris Isufi, Joseph M Tuscano, Nicole Lamanna, Suki Subbiah, Jean L. Koff, Lori Leslie, Alec Goldenberg, Gina G Chung, James B. Breitmeyer, Salim Yazji, Michael Wang, Catriona Jamieson, Thomas J. Kipps

Blood (2022) 140 (Supplement 1): 566–568.

https://doi.org/10.1182/blood-2022-167153

Published: 2022

Journal Articles

Modeling Premalignant Transformation of Hematopoietic Stem Cells in a Nanobioreactor in Microgravity

Luisa Ladel, Jessica Pham, Larissa Balaian, Kathleen Steel, Isabelle Oliver, Catriona Jamieson

Blood (2022) 140 (Supplement 1): 2982–2983.

https://doi.org/10.1182/blood-2022-168138

Published: 2022

Journal Articles

Deregulation of Splicing in Pediatric Acute Myeloid Stem and Progenitor Cells

Blood (2021) 138 (Supplement 1): 2227.

https://doi.org/10.1182/blood-2021-154120

Published: 2021

Journal Articles

ADAR1 Splicing Modulation As a Mechanism to Eradicate Immunologically Silent Leukemia Stem Cells

Leslie A Crews, Phoebe Mondala, Cayla Mason, Larisa Balaian, Wenxue Ma, Jessica Pham, Christina Wu, Peggy Wentworth, James La Clair, Michael Burkart, Catriona Jamieson

Blood (2021) 138 (Supplement 1): 3321.

https://doi.org/10.1182/blood-2021-154233

Published: 2021

Journal Articles

Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)

Hun Ju Lee, Michael Choi, Tanya Siddiqi, Jacqueline Barrientos, William G. Wierda, Iris Isufi, Joseph Tuscano, Nicole Lamanna, Suki Subbiah, Jean L. Koff, Lori A. Leslie, Alec Goldenberg, Gina G Chung, James B. Breitmeyer, Salim Yazji, Yao Wang, Michael Wang, Catriona Jamieson, Thomas J. Kipps

Blood (2021) 138 (Supplement 1): 3534.

https://doi.org/10.1182/blood-2021-148779

Published: 2021

Journal Articles

Selective Targeting of Alternative Splicing Deregulation in Pediatric Acute Myeloid Stem and Progenitor Cells

Inge Van Der Werf, MSc, Phoebe Mondala, BS, Raymond Diep, BS, Larissa Balaian, PhD, Cayla Mason, BS, Jacqueline Cloos, PhD, Gertjan J.L. Kaspers, Prof. MD PhD, Jim La Clair, Peggy Wentworth, Leslie A Crews, PhD, Thomas Whisenant, PhD, Kathleen Fisch, PhD, Michael Burkart, PhD, Catriona Jamieson, MD PhD

Blood (2020) 136 (Supplement 1): 8.

https://doi.org/10.1182/blood-2020-136596

Published: 2020

Journal Articles

Imetelstat Inhibits Telomerase and Prevents Propagation of ADAR1-Activated Myeloproliferative Neoplasm and Leukemia Stem Cells

Wenxue Ma, MD PhD, Larissa Balaian, PhD, Phoebe Mondala, BS, Yudou He, BS, Cayla Mason, BS, Jessica Pham, B.S., Jeremy Lee, BS, Raymond Diep, BS, Sanja Coso, PhD, Kathleen Fisch, PhD, Adam Mark, MS, Sheldon Morris, MD MPH, Qingfei Jiang, PhD, Thomas Whisenant, PhD, Aleksandra Rizo, MD PhD, Fei Huang, PhD, Mary Donohoe, PhD, Ludmil Alexandrov, PhD, Catriona Jamieson, MD PhD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-140771

Published: 2020

Journal Articles

Cirmtuzumab, an Anti-ROR1 Antibody, in Combination with Ibrutinib: Clinical Activity in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) from a Phase 1/2 Study

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-141917

Published: 2020

Journal Articles

Cirmtuzumab Consolidation for Treatment of Patients with Detectable CLL on Venetoclax

Benjamin Heyman, MD, Michael Y. Choi, MD, Emanuela M. Ghia, PhD, George F. Widhopf II, PhD, Minya Pu, PhD, Emily Pittman, PhD, Karen Messer, PhD, Catriona Jamieson, MD PhD, Thomas J. Kipps, MD PhD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-134711

Published: 2020

NARROW

A 3D Niche Nanobioreactor Supports Long-Term Tracking of Hematopoietic Stem and Progenitor Cell Cycle Kinetics, Self-Renewal and Cell Fate Determination

Space-Associated Stem and Hematopoietic Cell Aging in Astronauts on Short-Duration Missions

Selective Reversal of ADAR1 Splicing Prevents Leukemia Stem Cell Maintenance In Vivo

Identifying the Impact of ADAR1 Inhibition on LSC Niche Remodeling in 3D Nanobioreactors

Defining the Roles of Base Deaminase and Splicing Deregulation in Pediatric B-Cell Acute Lymphoblastic Leukemia Stem Cell Persistence

Malignant a-to-I RNA Editing By ADAR1 Drives T-Cell Acute Lymphoblastic Leukemia Relapse Via Attenuating dsRNA Sensing

A Longitudinal Study to Assess Hematopoietic Stem Cell and Immune Cell Health in Astronauts Pre-, during, and Post-Mission

Detection and Prevention of ADAR1p150-Induced Hematopoietic Stem and Progenitor Cell Aging

Getting to the core of ADAR2 activity in AML

Cirmtuzumab (Zilovertamab) Eliminates ROR1 Positive Leukemia Stem Cells By Blocking Niche Dependent ROR1/WNT5a Signaling

Decreased Embryonic Splicing Repressor Expression Enhances Splicing Modulator Sensitivity in Pediatric Acute Myeloid Leukemia Stem Cells

Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)

Modeling Premalignant Transformation of Hematopoietic Stem Cells in a Nanobioreactor in Microgravity

Deregulation of Splicing in Pediatric Acute Myeloid Stem and Progenitor Cells

ADAR1 Splicing Modulation As a Mechanism to Eradicate Immunologically Silent Leukemia Stem Cells

Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)

Selective Targeting of Alternative Splicing Deregulation in Pediatric Acute Myeloid Stem and Progenitor Cells

Imetelstat Inhibits Telomerase and Prevents Propagation of ADAR1-Activated Myeloproliferative Neoplasm and Leukemia Stem Cells

Cirmtuzumab, an Anti-ROR1 Antibody, in Combination with Ibrutinib: Clinical Activity in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) from a Phase 1/2 Study

Cirmtuzumab Consolidation for Treatment of Patients with Detectable CLL on Venetoclax

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only